 | • レポートコード：MRC2-11QY01156 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHGHバイオシミラーのグローバル市場について調査・分析したレポートです。種類別（臨床、実験）市場規模、用途別（治療、予防）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HGHバイオシミラーの競争状況、市場シェア ・世界のHGHバイオシミラー市場：種類別市場規模 2015年-2020年（臨床、実験） ・世界のHGHバイオシミラー市場：種類別市場規模予測 2021年-2026年（臨床、実験） ・世界のHGHバイオシミラー市場：用途別市場規模 2015年-2020年（治療、予防） ・世界のHGHバイオシミラー市場：用途別市場規模予測 2021年-2026年（治療、予防） ・北米のHGHバイオシミラー市場分析：米国、カナダ ・ヨーロッパのHGHバイオシミラー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHGHバイオシミラー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHGHバイオシミラー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHGHバイオシミラー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and Others
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Analysis and Insights: Global HGH Biosimilars Market
The global HGH Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HGH Biosimilars Scope and Market Size
HGH Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HGH Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the HGH Biosimilars market is segmented into
Clinical
Experiment
Segment by Application, the HGH Biosimilars market is segmented into
Treament
Prevention
Regional and Country-level Analysis
The HGH Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the HGH Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and HGH Biosimilars Market Share Analysis
HGH Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HGH Biosimilars business, the date to enter into the HGH Biosimilars market, HGH Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
1 Study Coverage
1.1 HGH Biosimilars Product Introduction
1.2 Market Segments
1.3 Key HGH Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global HGH Biosimilars Market Size Growth Rate by Type
1.4.2 Clinical
1.4.3 Experiment
1.5 Market by Application
1.5.1 Global HGH Biosimilars Market Size Growth Rate by Application
1.5.2 Treament
1.5.3 Prevention
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global HGH Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global HGH Biosimilars Revenue 2015-2026
2.1.2 Global HGH Biosimilars Sales 2015-2026
2.2 Global HGH Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global HGH Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global HGH Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global HGH Biosimilars Competitor Landscape by Players
3.1 HGH Biosimilars Sales by Manufacturers
3.1.1 HGH Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 HGH Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 HGH Biosimilars Revenue by Manufacturers
3.2.1 HGH Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 HGH Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global HGH Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by HGH Biosimilars Revenue in 2019
3.2.5 Global HGH Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 HGH Biosimilars Price by Manufacturers
3.4 HGH Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 HGH Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HGH Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into HGH Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HGH Biosimilars Market Size by Type (2015-2020)
4.1.1 Global HGH Biosimilars Sales by Type (2015-2020)
4.1.2 Global HGH Biosimilars Revenue by Type (2015-2020)
4.1.3 HGH Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global HGH Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global HGH Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global HGH Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 HGH Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global HGH Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global HGH Biosimilars Market Size by Application (2015-2020)
5.1.1 Global HGH Biosimilars Sales by Application (2015-2020)
5.1.2 Global HGH Biosimilars Revenue by Application (2015-2020)
5.1.3 HGH Biosimilars Price by Application (2015-2020)
5.2 HGH Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global HGH Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global HGH Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global HGH Biosimilars Price Forecast by Application (2021-2026)
6 North America
6.1 North America HGH Biosimilars by Country
6.1.1 North America HGH Biosimilars Sales by Country
6.1.2 North America HGH Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America HGH Biosimilars Market Facts & Figures by Type
6.3 North America HGH Biosimilars Market Facts & Figures by Application
7 Europe
7.1 Europe HGH Biosimilars by Country
7.1.1 Europe HGH Biosimilars Sales by Country
7.1.2 Europe HGH Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe HGH Biosimilars Market Facts & Figures by Type
7.3 Europe HGH Biosimilars Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific HGH Biosimilars by Region
8.1.1 Asia Pacific HGH Biosimilars Sales by Region
8.1.2 Asia Pacific HGH Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific HGH Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific HGH Biosimilars Market Facts & Figures by Application
9 Latin America
9.1 Latin America HGH Biosimilars by Country
9.1.1 Latin America HGH Biosimilars Sales by Country
9.1.2 Latin America HGH Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America HGH Biosimilars Market Facts & Figures by Type
9.3 Central & South America HGH Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa HGH Biosimilars by Country
10.1.1 Middle East and Africa HGH Biosimilars Sales by Country
10.1.2 Middle East and Africa HGH Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa HGH Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa HGH Biosimilars Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson HGH Biosimilars Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Description and Business Overview
11.2.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Gilead Sciences HGH Biosimilars Products Offered
11.2.5 Gilead Sciences Related Developments
11.3 Pacira
11.3.1 Pacira Corporation Information
11.3.2 Pacira Description and Business Overview
11.3.3 Pacira Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pacira HGH Biosimilars Products Offered
11.3.5 Pacira Related Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Description and Business Overview
11.4.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sun Pharmaceutical HGH Biosimilars Products Offered
11.4.5 Sun Pharmaceutical Related Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Description and Business Overview
11.5.3 Luye Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Luye Pharma HGH Biosimilars Products Offered
11.5.5 Luye Pharma Related Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Corporation Information
11.6.2 Sigma-Tau Group Description and Business Overview
11.6.3 Sigma-Tau Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sigma-Tau Group HGH Biosimilars Products Offered
11.6.5 Sigma-Tau Group Related Developments
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Corporation Information
11.7.2 Fudan-Zhangjiang Description and Business Overview
11.7.3 Fudan-Zhangjiang Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Fudan-Zhangjiang HGH Biosimilars Products Offered
11.7.5 Fudan-Zhangjiang Related Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Description and Business Overview
11.8.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teva Pharmaceutical HGH Biosimilars Products Offered
11.8.5 Teva Pharmaceutical Related Developments
11.9 CSPC
11.9.1 CSPC Corporation Information
11.9.2 CSPC Description and Business Overview
11.9.3 CSPC Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CSPC HGH Biosimilars Products Offered
11.9.5 CSPC Related Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description and Business Overview
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis HGH Biosimilars Products Offered
11.10.5 Novartis Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson HGH Biosimilars Products Offered
11.1.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 HGH Biosimilars Market Estimates and Projections by Region
12.1.1 Global HGH Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global HGH Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America HGH Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: HGH Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: HGH Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: HGH Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe HGH Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: HGH Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: HGH Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: HGH Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific HGH Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: HGH Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: HGH Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: HGH Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America HGH Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: HGH Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: HGH Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: HGH Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa HGH Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: HGH Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: HGH Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: HGH Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key HGH Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 HGH Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. HGH Biosimilars Market Segments
Table 2. Ranking of Global Top HGH Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global HGH Biosimilars Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Clinical
Table 5. Major Manufacturers of Experiment
Table 6. Global HGH Biosimilars Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global HGH Biosimilars Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global HGH Biosimilars Sales by Regions 2015-2020 (K Units)
Table 9. Global HGH Biosimilars Sales Market Share by Regions (2015-2020)
Table 10. Global HGH Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global HGH Biosimilars Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global HGH Biosimilars Sales Share by Manufacturers (2015-2020)
Table 13. Global HGH Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global HGH Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HGH Biosimilars as of 2019)
Table 15. HGH Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. HGH Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers HGH Biosimilars Price (2015-2020) (USD/Unit)
Table 18. HGH Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers HGH Biosimilars Product Type
Table 20. Date of International Manufacturers Enter into HGH Biosimilars Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global HGH Biosimilars Sales by Type (2015-2020) (K Units)
Table 23. Global HGH Biosimilars Sales Share by Type (2015-2020)
Table 24. Global HGH Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 25. Global HGH Biosimilars Revenue Share by Type (2015-2020)
Table 26. HGH Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global HGH Biosimilars Sales by Application (2015-2020) (K Units)
Table 28. Global HGH Biosimilars Sales Share by Application (2015-2020)
Table 29. North America HGH Biosimilars Sales by Country (2015-2020) (K Units)
Table 30. North America HGH Biosimilars Sales Market Share by Country (2015-2020)
Table 31. North America HGH Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 32. North America HGH Biosimilars Revenue Market Share by Country (2015-2020)
Table 33. North America HGH Biosimilars Sales by Type (2015-2020) (K Units)
Table 34. North America HGH Biosimilars Sales Market Share by Type (2015-2020)
Table 35. North America HGH Biosimilars Sales by Application (2015-2020) (K Units)
Table 36. North America HGH Biosimilars Sales Market Share by Application (2015-2020)
Table 37. Europe HGH Biosimilars Sales by Country (2015-2020) (K Units)
Table 38. Europe HGH Biosimilars Sales Market Share by Country (2015-2020)
Table 39. Europe HGH Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe HGH Biosimilars Revenue Market Share by Country (2015-2020)
Table 41. Europe HGH Biosimilars Sales by Type (2015-2020) (K Units)
Table 42. Europe HGH Biosimilars Sales Market Share by Type (2015-2020)
Table 43. Europe HGH Biosimilars Sales by Application (2015-2020) (K Units)
Table 44. Europe HGH Biosimilars Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific HGH Biosimilars Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific HGH Biosimilars Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific HGH Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific HGH Biosimilars Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific HGH Biosimilars Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific HGH Biosimilars Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific HGH Biosimilars Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific HGH Biosimilars Sales Market Share by Application (2015-2020)
Table 53. Latin America HGH Biosimilars Sales by Country (2015-2020) (K Units)
Table 54. Latin America HGH Biosimilars Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa HGH Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America HGH Biosimilars Revenue Market Share by Country (2015-2020)
Table 57. Latin America HGH Biosimilars Sales by Type (2015-2020) (K Units)
Table 58. Latin America HGH Biosimilars Sales Market Share by Type (2015-2020)
Table 59. Latin America HGH Biosimilars Sales by Application (2015-2020) (K Units)
Table 60. Latin America HGH Biosimilars Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa HGH Biosimilars Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa HGH Biosimilars Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa HGH Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa HGH Biosimilars Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa HGH Biosimilars Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa HGH Biosimilars Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa HGH Biosimilars Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa HGH Biosimilars Sales Market Share by Application (2015-2020)
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Description and Major Businesses
Table 71. Johnson & Johnson HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Recent Development
Table 74. Gilead Sciences Corporation Information
Table 75. Gilead Sciences Description and Major Businesses
Table 76. Gilead Sciences HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Gilead Sciences Product
Table 78. Gilead Sciences Recent Development
Table 79. Pacira Corporation Information
Table 80. Pacira Description and Major Businesses
Table 81. Pacira HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Pacira Product
Table 83. Pacira Recent Development
Table 84. Sun Pharmaceutical Corporation Information
Table 85. Sun Pharmaceutical Description and Major Businesses
Table 86. Sun Pharmaceutical HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sun Pharmaceutical Product
Table 88. Sun Pharmaceutical Recent Development
Table 89. Luye Pharma Corporation Information
Table 90. Luye Pharma Description and Major Businesses
Table 91. Luye Pharma HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Luye Pharma Product
Table 93. Luye Pharma Recent Development
Table 94. Sigma-Tau Group Corporation Information
Table 95. Sigma-Tau Group Description and Major Businesses
Table 96. Sigma-Tau Group HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Sigma-Tau Group Product
Table 98. Sigma-Tau Group Recent Development
Table 99. Fudan-Zhangjiang Corporation Information
Table 100. Fudan-Zhangjiang Description and Major Businesses
Table 101. Fudan-Zhangjiang HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Fudan-Zhangjiang Product
Table 103. Fudan-Zhangjiang Recent Development
Table 104. Teva Pharmaceutical Corporation Information
Table 105. Teva Pharmaceutical Description and Major Businesses
Table 106. Teva Pharmaceutical HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Teva Pharmaceutical Product
Table 108. Teva Pharmaceutical Recent Development
Table 109. CSPC Corporation Information
Table 110. CSPC Description and Major Businesses
Table 111. CSPC HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. CSPC Product
Table 113. CSPC Recent Development
Table 114. Novartis Corporation Information
Table 115. Novartis Description and Major Businesses
Table 116. Novartis HGH Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Novartis Product
Table 118. Novartis Recent Development
Table 119. Kingond Pharm Corporation Information
Table 120. Kingond Pharm Description and Major Businesses
Table 121. Kingond Pharm HGH Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Kingond Pharm Product
Table 123. Kingond Pharm Recent Development
Table 124. Global HGH Biosimilars Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global HGH Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global HGH Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global HGH Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: HGH Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: HGH Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: HGH Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: HGH Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: HGH Biosimilars Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: HGH Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: HGH Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: HGH Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: HGH Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: HGH Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key HGH Biosimilars Players
Table 142. HGH Biosimilars Customers List
Table 143. HGH Biosimilars Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. HGH Biosimilars Product Picture
Figure 2. Global HGH Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Clinical Product Picture
Figure 4. Experiment Product Picture
Figure 5. Global HGH Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 6. Treament
Figure 7. Prevention
Figure 8. HGH Biosimilars Report Years Considered
Figure 9. Global HGH Biosimilars Market Size 2015-2026 (US$ Million)
Figure 10. Global HGH Biosimilars Sales 2015-2026 (K Units)
Figure 11. Global HGH Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global HGH Biosimilars Sales Market Share by Region (2015-2020)
Figure 13. Global HGH Biosimilars Sales Market Share by Region in 2019
Figure 14. Global HGH Biosimilars Revenue Market Share by Region (2015-2020)
Figure 15. Global HGH Biosimilars Revenue Market Share by Region in 2019
Figure 16. Global HGH Biosimilars Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by HGH Biosimilars Revenue in 2019
Figure 18. HGH Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global HGH Biosimilars Sales Market Share by Type (2015-2020)
Figure 20. Global HGH Biosimilars Sales Market Share by Type in 2019
Figure 21. Global HGH Biosimilars Revenue Market Share by Type (2015-2020)
Figure 22. Global HGH Biosimilars Revenue Market Share by Type in 2019
Figure 23. Global HGH Biosimilars Market Share by Price Range (2015-2020)
Figure 24. Global HGH Biosimilars Sales Market Share by Application (2015-2020)
Figure 25. Global HGH Biosimilars Sales Market Share by Application in 2019
Figure 26. Global HGH Biosimilars Revenue Market Share by Application (2015-2020)
Figure 27. Global HGH Biosimilars Revenue Market Share by Application in 2019
Figure 28. North America HGH Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America HGH Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America HGH Biosimilars Sales Market Share by Country in 2019
Figure 31. North America HGH Biosimilars Revenue Market Share by Country in 2019
Figure 32. U.S. HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America HGH Biosimilars Market Share by Type in 2019
Figure 37. North America HGH Biosimilars Market Share by Application in 2019
Figure 38. Europe HGH Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe HGH Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe HGH Biosimilars Sales Market Share by Country in 2019
Figure 41. Europe HGH Biosimilars Revenue Market Share by Country in 2019
Figure 42. Germany HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 45. France HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe HGH Biosimilars Market Share by Type in 2019
Figure 53. Europe HGH Biosimilars Market Share by Application in 2019
Figure 54. Asia Pacific HGH Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific HGH Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific HGH Biosimilars Sales Market Share by Region in 2019
Figure 57. Asia Pacific HGH Biosimilars Revenue Market Share by Region in 2019
Figure 58. China HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 59. China HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 65. India HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific HGH Biosimilars Market Share by Type in 2019
Figure 81. Asia Pacific HGH Biosimilars Market Share by Application in 2019
Figure 82. Latin America HGH Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America HGH Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America HGH Biosimilars Sales Market Share by Country in 2019
Figure 85. Latin America HGH Biosimilars Revenue Market Share by Country in 2019
Figure 86. Mexico HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America HGH Biosimilars Market Share by Type in 2019
Figure 93. Latin America HGH Biosimilars Market Share by Application in 2019
Figure 94. Middle East and Africa HGH Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa HGH Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa HGH Biosimilars Sales Market Share by Country in 2019
Figure 97. Middle East and Africa HGH Biosimilars Revenue Market Share by Country in 2019
Figure 98. Turkey HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E HGH Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E HGH Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa HGH Biosimilars Market Share by Type in 2019
Figure 105. Middle East and Africa HGH Biosimilars Market Share by Application in 2019
Figure 106. North America HGH Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America HGH Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe HGH Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe HGH Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific HGH Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific HGH Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America HGH Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America HGH Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa HGH Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa HGH Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- G-CSF・G-CSFバイオシミラーの世界市場（～2026年） G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimu…
- G-CSFバイオシミラーの世界市場（～2026年） Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are…
- 生物製剤・バイオシミラーの世界市場（～2026年） Market Analysis and Insights: Global Biologics & Biosimilars Market The global Biologics & Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biologics & Biosimilars Scope and Market Size Biologics & Biosimila…